FDA import alert status
Jiangsu Grand Xinyi Pharmaceutical Co., Ltd
China · appears on 2 FDA import alerts
2
Red-list alerts
0
Green-list alerts
0
Yellow-list alerts
China
Country
2026-09-15
Latest indexed date
What this means
As published on the official FDA import alert list, this firm appears on 2 red lists. A red-list firm is subject to Detention Without Physical Examination (DWPE): FDA can detain its shipments at the border automatically, without sampling. The burden shifts to the importer to prove the goods are not violative.
Import alert status changes over time. Import Alert Radar re-checks the official FDA source every day; the entries below reflect the latest refresh (2026-11-22 UTC).
New · one-time pilot
Need a dated supplier record now?
Get a source-linked Supplier Evidence Snapshot for Jiangsu Grand Xinyi Pharmaceutical Co., Ltd: current red / green-list status, every matching FDA import alert, dates, official links and the dataset timestamp — prepared for your supplier file.
Informational evidence record, not legal advice or an FDA/FSVP certification.
Do you buy from Jiangsu Grand Xinyi Pharmaceutical Co., Ltd?
Review this supplier's current records and official source links for free. Watch subscriptions and automated email alerts are not available to start.
Red-list entries
- Import Alert 66-66RED · 11/21/2014
APIs That Appear To Be Misbranded Under 502(f)(1) Because They Do Not Meet The Requirements For The Labeling Exemptions In 21 CFR 201.122
- Import Alert 66-79RED · 09/15/2026
Detention Without Physical Examination of Drugs From Foreign Establishments Refusing FDA Inspection
Is Jiangsu Grand Xinyi Pharmaceutical Co., Ltd in your supply chain? Check monitoring availability
